Abbott has received european approval to market a dual glucose-ketone sensor, which is reportedly the world's first such device, intended for people with diabetes. The approval is denoted by a ce mark, which indicates conformity with certain european health and safety standards. Other recent abbott developments are also being reported, but the specifics of the dual glucose-ketone sensor approval are the primary focus of several outlets.